In the last 12 months, insiders at Travere Therapeutics, Inc. ($TVTX) filed 277 transactions with the SEC: 0 open-market purchases totaling $0 and 110 sales totaling $31,273,863. Net insider sentiment: net selling.
Travere Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Dube Eric M (CHIEF EXECUTIVE OFFICER) — 38 transactions totaling $19,358,896
- Calvin Sandra (SVP, CHIEF ACCOUNTING OFFICER) — 44 transactions totaling $7,508,496
- ROTE WILLIAM E. (Chief Research Officer) — 9 transactions totaling $4,119,198
- REED ELIZABETH E (Chief Legal Officer and GC) — 24 transactions totaling $2,730,782
- Cline Christopher R. (CHIEF FINANCIAL OFFICER) — 27 transactions totaling $1,565,602
View all SEC Filings for Travere Therapeutics, Inc. (TVTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Employee stock option (right to buy) | 10000 | $0.00 | 45,000.0000 | 89,211,813 | 18.18% | 0.01% |
| April 1, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 60000 | $15.46 | 492,886.0000 | 89,211,813 | 13.86% | 0.07% |
| April 1, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 34902 | $30.55 | 457,984.0000 | 89,211,813 | 7.08% | 0.04% |
| April 1, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 25098 | $31.46 | 432,886.0000 | 89,211,813 | 5.48% | 0.03% |
| April 1, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 60000 | $0.00 | 0.0000 | 89,211,813 | 100.00% | 0.07% |
| April 1, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Common Stock | 10000 | $15.46 | 115,211.0000 | 89,211,813 | 9.50% | 0.01% |
| April 1, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 10000 | $30.00 | 105,211.0000 | 89,211,813 | 8.68% | 0.01% |
| March 16, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 10000 | $28.09 | 105,211.0000 | 89,211,813 | 8.68% | 0.01% |
| March 16, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Employee stock option (right to buy) | 10000 | $0.00 | 10,000.0000 | 89,211,813 | 50.00% | 0.01% |
| March 16, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Common Stock | 10000 | $19.08 | 115,211.0000 | 89,211,813 | 9.50% | 0.01% |
| Feb. 20, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 89,211,813 | 50.00% | 0.07% |
| Feb. 20, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 60000 | $15.46 | 492,886.0000 | 89,211,813 | 13.86% | 0.07% |
| Feb. 20, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 60000 | $30.10 | 432,886.0000 | 89,211,813 | 12.17% | 0.07% |
| Feb. 17, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Employee stock option (right to buy) | 10000 | $0.00 | 20,000.0000 | 89,211,813 | 33.33% | 0.01% |
| Feb. 17, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Common Stock | 10000 | $19.08 | 115,211.0000 | 89,211,813 | 9.50% | 0.01% |
| Feb. 17, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 5679 | $27.50 | 109,532.0000 | 89,211,813 | 4.93% | 0.01% |
| Feb. 17, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 4321 | $28.26 | 105,211.0000 | 89,211,813 | 3.94% | 0.00% |
| Feb. 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 1547 | $32.11 | 105,938.0000 | 89,211,813 | 1.44% | 0.00% |
| Feb. 4, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 2485 | $32.07 | 105,720.0000 | 89,211,813 | 2.30% | 0.00% |
| Feb. 4, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 509 | $32.74 | 105,211.0000 | 89,211,813 | 0.48% | 0.00% |
| Feb. 4, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 1635 | $32.14 | 111,336.0000 | 89,211,813 | 1.45% | 0.00% |
| Feb. 4, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 110 | $32.90 | 111,226.0000 | 89,211,813 | 0.10% | 0.00% |
| Feb. 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 232 | $32.85 | 105,706.0000 | 89,211,813 | 0.22% | 0.00% |
| Jan. 31, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Employee stock option (right to buy) | 75000 | $0.00 | 75,000.0000 | 89,211,813 | 9999.99% | 0.08% |
| Jan. 31, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Common Stock | 113800 | $0.00 | 532,973.0000 | 89,211,813 | 27.15% | 0.13% |
| Feb. 3, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 66452 | $32.06 | 466,521.0000 | 89,211,813 | 12.47% | 0.07% |
| Feb. 3, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 33635 | $32.70 | 432,886.0000 | 89,211,813 | 7.21% | 0.04% |
| Jan. 31, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Employee stock option (right to buy) | 303600 | $0.00 | 303,600.0000 | 89,211,813 | 9999.99% | 0.34% |
| Jan. 31, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Common Stock | 28130 | $0.00 | 114,441.0000 | 89,211,813 | 32.59% | 0.03% |
| Feb. 3, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 6956 | $32.12 | 107,485.0000 | 89,211,813 | 6.08% | 0.01% |
| Jan. 31, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Employee stock option (right to buy) | 75000 | $0.00 | 75,000.0000 | 89,211,813 | 9999.99% | 0.08% |
| Jan. 31, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 28130 | $0.00 | 120,213.0000 | 89,211,813 | 30.55% | 0.03% |
| Jan. 31, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | A | Employee stock option (right to buy) | 66960 | $0.00 | 66,960.0000 | 89,211,813 | 9999.99% | 0.08% |
| Feb. 3, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 7175 | $32.12 | 108,205.0000 | 89,211,813 | 6.22% | 0.01% |
| Jan. 31, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | A | Common Stock | 25110 | $0.00 | 115,380.0000 | 89,211,813 | 27.82% | 0.03% |
| Jan. 31, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Employee stock option (right to buy) | 20160 | $0.00 | 20,160.0000 | 89,211,813 | 9999.99% | 0.02% |
| Feb. 3, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 4333 | $32.12 | 49,080.0000 | 89,211,813 | 8.11% | 0.00% |
| Jan. 31, 2026 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Common Stock | 15180 | $0.00 | 53,413.0000 | 89,211,813 | 39.70% | 0.02% |
| Jan. 31, 2026 | ROTE WILLIAM E. | Chief Research Officer | A | Employee stock option (right to buy) | 53570 | $0.00 | 53,570.0000 | 89,211,813 | 9999.99% | 0.06% |
| Feb. 3, 2026 | ROTE WILLIAM E. | Chief Research Officer | S | Common Stock | 12446 | $32.87 | 109,087.0000 | 89,211,813 | 10.24% | 0.01% |
| Jan. 31, 2026 | ROTE WILLIAM E. | Chief Research Officer | A | Common Stock | 20090 | $0.00 | 121,533.0000 | 89,211,813 | 19.80% | 0.02% |
| Jan. 31, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Employee stock option (right to buy) | 69640 | $0.00 | 69,640.0000 | 89,211,813 | 9999.99% | 0.08% |
| Feb. 3, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 7310 | $32.12 | 131,823.0000 | 89,211,813 | 5.25% | 0.01% |
| Jan. 31, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Common Stock | 26120 | $0.00 | 139,133.0000 | 89,211,813 | 23.11% | 0.03% |
| Feb. 3, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 7242 | $32.12 | 112,971.0000 | 89,211,813 | 6.02% | 0.01% |
| Jan. 23, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 8135 | $0.00 | 171,865.0000 | 89,211,813 | 4.52% | 0.01% |
| Jan. 27, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 51865 | $0.00 | 120,000.0000 | 89,211,813 | 30.18% | 0.06% |
| Jan. 27, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 51865 | $30.10 | 419,173.0000 | 89,211,813 | 11.01% | 0.06% |
| Jan. 23, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 8135 | $30.01 | 419,173.0000 | 89,211,813 | 1.90% | 0.01% |
| Jan. 23, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 8135 | $15.46 | 427,308.0000 | 89,211,813 | 1.94% | 0.01% |
| Jan. 27, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 51865 | $15.46 | 471,038.0000 | 89,211,813 | 12.37% | 0.06% |
| Jan. 20, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Common Stock | 10000 | $19.08 | 100,270.0000 | 89,211,813 | 11.08% | 0.01% |
| Jan. 20, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 10000 | $27.34 | 90,270.0000 | 89,211,813 | 9.97% | 0.01% |
| Jan. 20, 2026 | REED ELIZABETH E | Chief Legal Officer and GC | M | Employee stock option (right to buy) | 10000 | $0.00 | 30,000.0000 | 89,211,813 | 25.00% | 0.01% |
| Jan. 5, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 2031 | $40.18 | 86,756.0000 | 89,211,813 | 2.29% | 0.00% |
| Jan. 6, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 445 | $37.75 | 86,311.0000 | 89,211,813 | 0.51% | 0.00% |
| Dec. 24, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 15000 | $42.00 | 88,787.0000 | 102,618,560 | 14.45% | 0.01% |
| Dec. 24, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | M | Common Stock | 15000 | $8.93 | 103,787.0000 | 102,618,560 | 16.89% | 0.01% |
| Dec. 24, 2025 | ROTE WILLIAM E. | Chief Research Officer | M | Employee stock option (right to buy) | 60000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.06% |
| Dec. 24, 2025 | ROTE WILLIAM E. | Chief Research Officer | S | Common Stock | 60000 | $40.10 | 101,443.0000 | 102,618,560 | 37.16% | 0.06% |
| Dec. 24, 2025 | ROTE WILLIAM E. | Chief Research Officer | M | Common Stock | 60000 | $20.61 | 161,443.0000 | 102,618,560 | 59.15% | 0.06% |
| Dec. 24, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 4980 | $40.00 | 113,013.0000 | 102,618,560 | 4.22% | 0.00% |
| Dec. 24, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 7402 | $40.00 | 38,233.0000 | 102,618,560 | 16.22% | 0.01% |
| Dec. 24, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | M | Employee stock option (right to buy) | 15000 | $0.00 | 76,000.0000 | 102,618,560 | 16.48% | 0.01% |
| Dec. 15, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 2910 | $36.00 | 45,635.0000 | 102,618,560 | 5.99% | 0.00% |
| Dec. 1, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | M | Employee stock option (right to buy) | 20000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.02% |
| Dec. 1, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | M | Common Stock | 20000 | $16.23 | 112,083.0000 | 102,618,560 | 21.72% | 0.02% |
| Dec. 1, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 20000 | $35.01 | 92,083.0000 | 102,618,560 | 17.84% | 0.02% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 12500 | $0.00 | 7,500.0000 | 102,618,560 | 62.50% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 6250 | $0.00 | 18,750.0000 | 102,618,560 | 25.00% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 15000 | $0.00 | 2,500.0000 | 102,618,560 | 85.71% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 17500 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.02% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 10000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 67115 | $36.00 | 48,545.0000 | 102,618,560 | 58.03% | 0.07% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 6250 | $8.93 | 115,660.0000 | 102,618,560 | 5.71% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 12500 | $22.40 | 109,410.0000 | 102,618,560 | 12.90% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 15000 | $27.50 | 96,910.0000 | 102,618,560 | 18.31% | 0.01% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 17500 | $26.88 | 81,910.0000 | 102,618,560 | 27.17% | 0.02% |
| Nov. 4, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 10000 | $25.25 | 64,410.0000 | 102,618,560 | 18.38% | 0.01% |
| Nov. 3, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | G | Common Stock | 1078 | $0.00 | 117,993.0000 | 102,618,560 | 0.91% | 0.00% |
| Oct. 31, 2025 | Coughlin Timothy | Not found | M | Common Stock | 8000 | $16.33 | 63,500.0000 | 102,618,560 | 14.41% | 0.01% |
| Oct. 31, 2025 | Coughlin Timothy | Not found | M | Common Stock | 10000 | $17.44 | 73,500.0000 | 102,618,560 | 15.75% | 0.01% |
| Oct. 31, 2025 | Coughlin Timothy | Not found | S | Common Stock | 18000 | $35.03 | 55,500.0000 | 102,618,560 | 24.49% | 0.02% |
| Oct. 31, 2025 | Coughlin Timothy | Not found | M | Director stock option (right to buy) | 8000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.01% |
| Oct. 31, 2025 | Coughlin Timothy | Not found | M | Director stock option (right to buy) | 10000 | $0.00 | 0.0000 | 102,618,560 | 100.00% | 0.01% |
| Oct. 31, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 5591 | $35.00 | 119,071.0000 | 102,618,560 | 4.48% | 0.01% |
| Oct. 28, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 92872 | $15.46 | 512,045.0000 | 102,618,560 | 22.16% | 0.09% |
| Oct. 28, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 92872 | $0.00 | 207,128.0000 | 102,618,560 | 30.96% | 0.09% |
| Oct. 28, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 2662 | $30.00 | 124,662.0000 | 102,618,560 | 2.09% | 0.00% |
| Oct. 29, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Employee stock option (right to buy) | 27128 | $0.00 | 180,000.0000 | 102,618,560 | 13.10% | 0.03% |
| Oct. 28, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 92872 | $30.38 | 419,173.0000 | 102,618,560 | 18.14% | 0.09% |
| Oct. 29, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 27128 | $15.46 | 446,301.0000 | 102,618,560 | 6.47% | 0.03% |
| Oct. 29, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 27128 | $30.12 | 419,173.0000 | 102,618,560 | 6.08% | 0.03% |
| Sept. 22, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | M | Common Stock | 10000 | $19.08 | 99,878.0000 | 78,888,861 | 11.13% | 0.01% |
| Sept. 22, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 10000 | $25.00 | 89,878.0000 | 78,888,861 | 10.01% | 0.01% |
| Sept. 22, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | M | Employee stock option (right to buy) | 10000 | $0.00 | 40,000.0000 | 78,888,861 | 20.00% | 0.01% |
| Sept. 23, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | G | Common Stock | 891 | $0.00 | 127,324.0000 | 78,888,861 | 0.69% | 0.00% |
| Sept. 3, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 454 | $18.20 | 92,202.0000 | 78,888,861 | 0.49% | 0.00% |
| Sept. 4, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 119 | $19.71 | 92,083.0000 | 78,888,861 | 0.13% | 0.00% |
| Aug. 27, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 470 | $17.31 | 92,656.0000 | 78,888,861 | 0.50% | 0.00% |
| July 1, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 815 | $14.65 | 88,787.0000 | 78,888,861 | 0.91% | 0.00% |
| May 15, 2025 | LYONS GARY A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Baynes Roy D. | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Baynes Roy D. | Not found | A | Common Stock | 6500 | $0.00 | 37,500.0000 | 78,888,861 | 20.97% | 0.01% |
| May 15, 2025 | Bruhn Suzanne Louise | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Bruhn Suzanne Louise | Not found | A | Common Stock | 6500 | $0.00 | 28,750.0000 | 78,888,861 | 29.21% | 0.01% |
| May 15, 2025 | COUGHLIN TIMOTHY | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | COUGHLIN TIMOTHY | Not found | A | Common Stock | 6500 | $0.00 | 55,500.0000 | 78,888,861 | 13.27% | 0.01% |
| May 15, 2025 | LYONS GARY A | Not found | A | Common Stock | 6500 | $0.00 | 57,500.0000 | 78,888,861 | 12.75% | 0.01% |
| May 15, 2025 | Meckler Jeffrey A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Meckler Jeffrey A | Not found | A | Common Stock | 6500 | $0.00 | 87,500.0000 | 78,888,861 | 8.02% | 0.01% |
| May 15, 2025 | Orwin John A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Orwin John A | Not found | A | Common Stock | 6500 | $0.00 | 35,375.0000 | 78,888,861 | 22.51% | 0.01% |
| May 15, 2025 | Poole Sandra | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Poole Sandra | Not found | A | Common Stock | 6500 | $0.00 | 30,000.0000 | 78,888,861 | 27.66% | 0.01% |
| May 15, 2025 | Squarer Ron | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Squarer Ron | Not found | A | Common Stock | 6500 | $0.00 | 35,375.0000 | 78,888,861 | 22.51% | 0.01% |
| May 15, 2025 | Williams Brinkley Ruth | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 15, 2025 | Williams Brinkley Ruth | Not found | A | Common Stock | 6500 | $0.00 | 25,750.0000 | 78,888,861 | 33.77% | 0.01% |
| May 2, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Performance-based restricted stock units | 18924 | $0.00 | 18,924.0000 | 78,888,861 | 50.00% | 0.02% |
| May 2, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | M | Common Stock | 4920 | $0.00 | 94,910.0000 | 78,888,861 | 5.47% | 0.01% |
| May 5, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 1784 | $21.05 | 93,126.0000 | 78,888,861 | 1.88% | 0.00% |
| May 2, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | M | Performance-based restricted stock units | 4920 | $0.00 | 4,920.0000 | 78,888,861 | 50.00% | 0.01% |
| May 2, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | M | Common Stock | 18924 | $0.00 | 438,097.0000 | 78,888,861 | 4.51% | 0.02% |
| May 5, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 18924 | $21.05 | 419,173.0000 | 78,888,861 | 4.32% | 0.02% |
| May 2, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | M | Performance-based restricted stock units | 4920 | $0.00 | 4,920.0000 | 78,888,861 | 50.00% | 0.01% |
| May 5, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | S | Common Stock | 4920 | $21.05 | 89,482.0000 | 78,888,861 | 5.21% | 0.01% |
| May 2, 2025 | REED ELIZABETH E | Chief Legal Officer and GC | M | Common Stock | 4920 | $0.00 | 94,402.0000 | 78,888,861 | 5.50% | 0.01% |
| May 2, 2025 | ROTE WILLIAM E. | Chief Research Officer | M | Performance-based restricted stock units | 4920 | $0.00 | 4,920.0000 | 78,888,861 | 50.00% | 0.01% |
| May 5, 2025 | ROTE WILLIAM E. | Chief Research Officer | S | Common Stock | 3198 | $21.05 | 100,241.0000 | 78,888,861 | 3.09% | 0.00% |
| May 2, 2025 | ROTE WILLIAM E. | Chief Research Officer | M | Common Stock | 4920 | $0.00 | 103,439.0000 | 78,888,861 | 4.99% | 0.01% |
| May 2, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | M | Performance-based restricted stock units | 4920 | $0.00 | 4,920.0000 | 78,888,861 | 50.00% | 0.01% |
| May 5, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1771 | $21.05 | 128,215.0000 | 78,888,861 | 1.36% | 0.00% |
| May 2, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | M | Common Stock | 4920 | $0.00 | 129,986.0000 | 78,888,861 | 3.93% | 0.01% |
| April 11, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 48 | $13.14 | 89,990.0000 | 78,888,861 | 0.05% | 0.00% |
| Feb. 10, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | M | Performance-based restricted stock units | 8000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 12, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 5200 | $23.53 | 98,519.0000 | 78,888,861 | 5.01% | 0.01% |
| Feb. 10, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | M | Common Stock | 8000 | $0.00 | 103,719.0000 | 78,888,861 | 8.36% | 0.01% |
| Feb. 10, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | M | Performance-based restricted stock units | 8000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 10, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | M | Common Stock | 8000 | $0.00 | 97,482.0000 | 78,888,861 | 8.94% | 0.01% |
| Feb. 12, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 8000 | $23.53 | 89,482.0000 | 78,888,861 | 8.21% | 0.01% |
| Feb. 10, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | M | Performance-based restricted stock units | 8000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 10000 | $16.23 | 73,654.0000 | 78,888,861 | 15.71% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 10000 | $25.00 | 63,654.0000 | 78,888,861 | 13.58% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 10000 | $17.44 | 73,654.0000 | 78,888,861 | 15.71% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 10000 | $25.00 | 63,654.0000 | 78,888,861 | 13.58% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 10000 | $17.96 | 73,654.0000 | 78,888,861 | 15.71% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 10000 | $25.00 | 63,654.0000 | 78,888,861 | 13.58% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 15000 | $15.46 | 78,654.0000 | 78,888,861 | 23.56% | 0.02% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 15000 | $25.00 | 63,654.0000 | 78,888,861 | 19.07% | 0.02% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 9244 | $25.00 | 54,410.0000 | 78,888,861 | 14.52% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 10000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 10000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 10000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 15000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.02% |
| Feb. 10, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | M | Common Stock | 8000 | $0.00 | 130,708.0000 | 78,888,861 | 6.52% | 0.01% |
| Feb. 11, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 3074 | $25.00 | 127,634.0000 | 78,888,861 | 2.35% | 0.00% |
| Feb. 12, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 2568 | $23.53 | 125,066.0000 | 78,888,861 | 2.01% | 0.00% |
| Feb. 10, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | M | Performance-based restricted stock units | 8000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 11, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 11375 | $24.04 | 419,173.0000 | 78,888,861 | 2.64% | 0.01% |
| Feb. 10, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | M | Common Stock | 8000 | $0.00 | 92,170.0000 | 78,888,861 | 9.50% | 0.01% |
| Feb. 12, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 2568 | $23.53 | 89,602.0000 | 78,888,861 | 2.79% | 0.00% |
| Feb. 6, 2025 | Baynes Roy D. | Not found | S | Common Stock | 10000 | $22.00 | 31,000.0000 | 78,888,861 | 24.39% | 0.01% |
| Feb. 6, 2025 | Baynes Roy D. | Not found | M | Common Stock | 10000 | $17.44 | 41,000.0000 | 78,888,861 | 32.26% | 0.01% |
| Feb. 6, 2025 | Baynes Roy D. | Not found | M | Stock option (right to buy) | 10000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.01% |
| Feb. 4, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 1066 | $20.11 | 84,170.0000 | 78,888,861 | 1.25% | 0.00% |
| Jan. 31, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | A | Common Stock | 21500 | $0.00 | 104,670.0000 | 78,888,861 | 25.85% | 0.03% |
| Feb. 3, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 8951 | $19.78 | 95,719.0000 | 78,888,861 | 8.55% | 0.01% |
| Jan. 31, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | A | Employee stock option (right to buy) | 58000 | $0.00 | 58,000.0000 | 78,888,861 | 9999.99% | 0.07% |
| Jan. 31, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | A | Common Stock | 21500 | $0.00 | 98,433.0000 | 78,888,861 | 27.95% | 0.03% |
| Feb. 3, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 8951 | $19.78 | 89,482.0000 | 78,888,861 | 9.09% | 0.01% |
| Jan. 31, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | A | Employee stock option (right to buy) | 58000 | $0.00 | 58,000.0000 | 78,888,861 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Common Stock | 130000 | $0.00 | 481,239.0000 | 78,888,861 | 37.01% | 0.16% |
| Feb. 3, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 50691 | $20.21 | 430,548.0000 | 78,888,861 | 10.53% | 0.06% |
| Jan. 31, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Employee stock option (right to buy) | 260000 | $0.00 | 260,000.0000 | 78,888,861 | 9999.99% | 0.33% |
| Jan. 31, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Common Stock | 30000 | $0.00 | 89,443.0000 | 78,888,861 | 50.47% | 0.04% |
| Feb. 3, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 4207 | $20.12 | 85,236.0000 | 78,888,861 | 4.70% | 0.01% |
| Jan. 31, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 78,888,861 | 9999.99% | 0.13% |
| Jan. 31, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Common Stock | 21500 | $0.00 | 127,874.0000 | 78,888,861 | 20.21% | 0.03% |
| Feb. 3, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 5166 | $20.12 | 122,708.0000 | 78,888,861 | 4.04% | 0.01% |
| Jan. 31, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Employee stock option (right to buy) | 58000 | $0.00 | 58,000.0000 | 78,888,861 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 21500 | $0.00 | 95,230.0000 | 78,888,861 | 29.16% | 0.03% |
| Feb. 3, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 5192 | $20.12 | 90,038.0000 | 78,888,861 | 5.45% | 0.01% |
| Jan. 31, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Employee stock option (right to buy) | 58000 | $0.00 | 58,000.0000 | 78,888,861 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Common Stock | 13000 | $0.00 | 67,002.0000 | 78,888,861 | 24.07% | 0.02% |
| Feb. 3, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 3348 | $20.12 | 63,654.0000 | 78,888,861 | 5.00% | 0.00% |
| Jan. 31, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Employee stock option (right to buy) | 26000 | $0.00 | 26,000.0000 | 78,888,861 | 9999.99% | 0.03% |
| Jan. 22, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 925 | $18.94 | 54,002.0000 | 78,888,861 | 1.68% | 0.00% |
| Jan. 22, 2025 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1584 | $18.94 | 106,374.0000 | 78,888,861 | 1.47% | 0.00% |
| Jan. 22, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 865 | $18.94 | 73,730.0000 | 78,888,861 | 1.16% | 0.00% |
| Jan. 22, 2025 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10736 | $19.46 | 351,239.0000 | 78,888,861 | 2.97% | 0.01% |
| Jan. 22, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 2437 | $19.46 | 76,933.0000 | 78,888,861 | 3.07% | 0.00% |
| Jan. 23, 2025 | Baynes Roy D. | Not found | M | Common Stock | 16000 | $17.50 | 47,000.0000 | 78,888,861 | 51.61% | 0.02% |
| Jan. 23, 2025 | Baynes Roy D. | Not found | S | Common Stock | 16000 | $20.00 | 31,000.0000 | 78,888,861 | 34.04% | 0.02% |
| Jan. 23, 2025 | Baynes Roy D. | Not found | M | Stock option (right to buy) | 16000 | $0.00 | 0.0000 | 78,888,861 | 100.00% | 0.02% |
| Jan. 22, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 2437 | $19.46 | 83,170.0000 | 78,888,861 | 2.85% | 0.00% |
| Jan. 6, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 440 | $18.76 | 59,443.0000 | 78,888,861 | 0.73% | 0.00% |
| Jan. 3, 2025 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 2066 | $19.10 | 59,883.0000 | 78,888,861 | 3.34% | 0.00% |
| Dec. 26, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 15000 | $12.67 | 69,927.0000 | 77,779,379 | 27.31% | 0.02% |
| Dec. 26, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 15000 | $0.00 | 0.0000 | 77,779,379 | 100.00% | 0.02% |
| Dec. 26, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 15000 | $17.22 | 54,927.0000 | 77,779,379 | 21.45% | 0.02% |
| Nov. 25, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Common Stock | 15000 | $12.67 | 67,017.0000 | 77,779,379 | 28.84% | 0.02% |
| Nov. 25, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | M | Employee stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 77,779,379 | 50.00% | 0.02% |
| Nov. 25, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 12090 | $18.30 | 54,927.0000 | 77,779,379 | 18.04% | 0.02% |
| Oct. 4, 2024 | LYONS GARY A | Not found | S | Common Stock | 21179 | $14.35 | 69,821.0000 | 77,779,379 | 23.27% | 0.03% |
| Oct. 4, 2024 | LYONS GARY A | Not found | M | Stock option (right to buy) | 40000 | $0.00 | 0.0000 | 77,779,379 | 0.00% | 0.05% |
| Oct. 4, 2024 | LYONS GARY A | Not found | S | Common Stock | 18821 | $15.15 | 51,000.0000 | 77,779,379 | 26.96% | 0.02% |
| Oct. 4, 2024 | LYONS GARY A | Not found | M | Common Stock | 40000 | $10.48 | 91,000.0000 | 77,779,379 | 78.43% | 0.05% |
| Sept. 30, 2024 | Meckler Jeffrey A | Not found | M | Common Stock | 40000 | $10.48 | 121,000.0000 | 74,267,418 | 49.38% | 0.05% |
| Sept. 30, 2024 | Meckler Jeffrey A | Not found | S | Common Stock | 40000 | $14.06 | 81,000.0000 | 74,267,418 | 33.06% | 0.05% |
| Sept. 30, 2024 | Meckler Jeffrey A | Not found | M | Stock option (right to buy) | 40000 | $0.00 | 0.0000 | 74,267,418 | 0.00% | 0.05% |
| Sept. 10, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 684 | $12.98 | 61,949.0000 | 74,267,418 | 1.09% | 0.00% |
| Sept. 5, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | A | Common Stock | 6750 | $0.00 | 88,842.0000 | 74,267,418 | 8.22% | 0.01% |
| Sept. 9, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 4387 | $11.52 | 84,455.0000 | 74,267,418 | 4.94% | 0.01% |
| Sept. 5, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | A | Common Stock | 6750 | $0.00 | 83,020.0000 | 74,267,418 | 8.85% | 0.01% |
| Sept. 9, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 4387 | $11.52 | 78,633.0000 | 74,267,418 | 5.28% | 0.01% |
| Sept. 5, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Common Stock | 32500 | $0.00 | 383,100.0000 | 74,267,418 | 9.27% | 0.04% |
| Sept. 9, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 21125 | $11.52 | 361,975.0000 | 74,267,418 | 5.51% | 0.03% |
| Sept. 5, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Common Stock | 6750 | $0.00 | 64,824.0000 | 74,267,418 | 11.62% | 0.01% |
| Sept. 9, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 2191 | $11.52 | 62,633.0000 | 74,267,418 | 3.38% | 0.00% |
| Sept. 5, 2024 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Common Stock | 6750 | $0.00 | 110,149.0000 | 74,267,418 | 6.53% | 0.01% |
| Sept. 9, 2024 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 2191 | $11.52 | 107,958.0000 | 74,267,418 | 1.99% | 0.00% |
| Sept. 5, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 6750 | $0.00 | 77,085.0000 | 74,267,418 | 9.60% | 0.01% |
| Sept. 9, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 2490 | $11.52 | 74,595.0000 | 74,267,418 | 3.23% | 0.00% |
| Sept. 4, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 514 | $9.51 | 70,335.0000 | 74,267,418 | 0.73% | 0.00% |
| May 8, 2024 | Squarer Ron | Not found | A | Common Stock | 6500 | $0.00 | 28,875.0000 | 74,267,418 | 29.05% | 0.01% |
| May 8, 2024 | Squarer Ron | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Williams Brinkley Ruth | Not found | A | Common Stock | 6500 | $0.00 | 19,250.0000 | 74,267,418 | 50.98% | 0.01% |
| May 8, 2024 | Williams Brinkley Ruth | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Orwin John A | Not found | A | Common Stock | 6500 | $0.00 | 28,875.0000 | 74,267,418 | 29.05% | 0.01% |
| May 8, 2024 | Orwin John A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Poole Sandra | Not found | A | Common Stock | 6500 | $0.00 | 23,500.0000 | 74,267,418 | 38.24% | 0.01% |
| May 8, 2024 | LYONS GARY A | Not found | A | Common Stock | 6500 | $0.00 | 51,000.0000 | 74,267,418 | 14.61% | 0.01% |
| May 8, 2024 | Poole Sandra | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Meckler Jeffrey A | Not found | A | Common Stock | 6500 | $0.00 | 81,000.0000 | 74,267,418 | 8.72% | 0.01% |
| May 8, 2024 | Meckler Jeffrey A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | LYONS GARY A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | COUGHLIN TIMOTHY | Not found | A | Common Stock | 6500 | $0.00 | 49,000.0000 | 74,267,418 | 15.29% | 0.01% |
| May 8, 2024 | COUGHLIN TIMOTHY | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Bruhn Suzanne Louise | Not found | A | Common Stock | 6500 | $0.00 | 22,250.0000 | 74,267,418 | 41.27% | 0.01% |
| May 8, 2024 | Bruhn Suzanne Louise | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Baynes Roy D. | Not found | A | Common Stock | 6500 | $0.00 | 31,000.0000 | 74,267,418 | 26.53% | 0.01% |
| May 8, 2024 | Baynes Roy D. | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| April 11, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 54 | $6.74 | 70,849.0000 | 74,267,418 | 0.08% | 0.00% |
| Jan. 31, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Common Stock | 135000 | $0.00 | 369,722.0000 | 74,267,418 | 57.51% | 0.18% |
| Jan. 31, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Employee stock option (right to buy) | 65000 | $0.00 | 65,000.0000 | 74,267,418 | 9999.99% | 0.09% |
| Feb. 1, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 3818 | $8.53 | 70,903.0000 | 74,267,418 | 5.11% | 0.01% |
| Jan. 31, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | A | Common Stock | 25000 | $0.00 | 74,721.0000 | 74,267,418 | 50.28% | 0.03% |
| Jan. 31, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Employee stock option (right to buy) | 91000 | $0.00 | 91,000.0000 | 74,267,418 | 9999.99% | 0.12% |
| Feb. 1, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | S | Common Stock | 2174 | $8.53 | 58,074.0000 | 74,267,418 | 3.61% | 0.00% |
| Jan. 31, 2024 | Inrig Jula | CHIEF MEDICAL OFFICER | A | Common Stock | 25000 | $0.00 | 60,248.0000 | 74,267,418 | 70.93% | 0.03% |
| Jan. 31, 2024 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Employee stock option (right to buy) | 65000 | $0.00 | 65,000.0000 | 74,267,418 | 9999.99% | 0.09% |
| Feb. 1, 2024 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 4195 | $8.53 | 99,503.0000 | 74,267,418 | 4.05% | 0.01% |
| Jan. 31, 2024 | Heerma Peter | CHIEF COMMERCIAL OFFICER | A | Common Stock | 25000 | $0.00 | 103,698.0000 | 74,267,418 | 31.77% | 0.03% |
| Jan. 31, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | A | Employee stock option (right to buy) | 65000 | $0.00 | 65,000.0000 | 74,267,418 | 9999.99% | 0.09% |
| Feb. 1, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 2590 | $8.86 | 76,270.0000 | 74,267,418 | 3.28% | 0.00% |
| Feb. 1, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 2174 | $8.53 | 78,860.0000 | 74,267,418 | 2.68% | 0.00% |
| Jan. 31, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | A | Common Stock | 25000 | $0.00 | 81,034.0000 | 74,267,418 | 44.62% | 0.03% |
| Jan. 31, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Employee stock option (right to buy) | 25000 | $0.00 | 25,000.0000 | 74,267,418 | 9999.99% | 0.03% |
| Feb. 1, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 2820 | $8.53 | 52,017.0000 | 74,267,418 | 5.14% | 0.00% |
| Jan. 31, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Common Stock | 1000 | $0.00 | 54,837.0000 | 74,267,418 | 1.86% | 0.00% |
| Jan. 31, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | A | Common Stock | 12500 | $0.00 | 53,837.0000 | 74,267,418 | 30.24% | 0.02% |
| Jan. 31, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | A | Employee stock option (right to buy) | 65000 | $0.00 | 65,000.0000 | 74,267,418 | 9999.99% | 0.09% |
| Feb. 1, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 2590 | $8.86 | 80,720.0000 | 74,267,418 | 3.11% | 0.00% |
| Feb. 1, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 2174 | $8.53 | 83,310.0000 | 74,267,418 | 2.54% | 0.00% |
| Jan. 31, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | A | Common Stock | 25000 | $0.00 | 85,484.0000 | 74,267,418 | 41.33% | 0.03% |
| Jan. 31, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | A | Employee stock option (right to buy) | 360000 | $0.00 | 360,000.0000 | 74,267,418 | 9999.99% | 0.48% |
| Feb. 1, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 10016 | $8.86 | 350,600.0000 | 74,267,418 | 2.78% | 0.01% |
| Feb. 1, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 9106 | $8.53 | 360,616.0000 | 74,267,418 | 2.46% | 0.01% |
| Jan. 23, 2024 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | S | Common Stock | 2062 | $8.96 | 56,034.0000 | 74,267,418 | 3.55% | 0.00% |
| Jan. 23, 2024 | Dube Eric M | CHIEF EXECUTIVE OFFICER | S | Common Stock | 7873 | $8.96 | 234,722.0000 | 74,267,418 | 3.25% | 0.01% |
| Jan. 23, 2024 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | S | Common Stock | 853 | $9.07 | 49,721.0000 | 74,267,418 | 1.69% | 0.00% |
| Jan. 23, 2024 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | S | Common Stock | 2062 | $8.96 | 60,484.0000 | 74,267,418 | 3.30% | 0.00% |
| Jan. 23, 2024 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | S | Common Stock | 910 | $9.07 | 41,337.0000 | 74,267,418 | 2.15% | 0.00% |
| Jan. 23, 2024 | Heerma Peter | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1559 | $9.07 | 78,698.0000 | 74,267,418 | 1.94% | 0.00% |
| Jan. 3, 2024 | Inrig Jula | Chief Medical Officer | S | Common Stock | 2069 | $9.48 | 35,688.0000 | 74,267,418 | 5.48% | 0.00% |
| Jan. 4, 2024 | Inrig Jula | Chief Medical Officer | S | Common Stock | 440 | $9.17 | 35,248.0000 | 74,267,418 | 1.23% | 0.00% |